PubRank

Richard Iggo

Author PubWeight™ 28.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 2003 6.49
2 Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 2005 5.27
3 A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 2009 3.86
4 Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem 2003 2.02
5 TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial. Lancet Oncol 2011 1.85
6 Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res 2007 1.51
7 p53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients. Eur Arch Otorhinolaryngol 2008 1.42
8 Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res 2010 1.14
9 Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin Cancer Res 2009 1.04
10 Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic? Eur J Cancer 2009 0.91
11 Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir Ther 2003 0.91
12 Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Hum Gene Ther 2005 0.86
13 Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations. PLoS One 2012 0.78
14 Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors. Clin Cancer Res 2008 0.76